Eliezer Katz
About Eliezer Katz
Eliezer Katz is the Chief Medical Officer at Eledon Pharmaceuticals, with extensive experience in clinical development and transplantation surgery.
Chief Medical Officer at Eledon Pharmaceuticals
Eliezer Katz serves as the Chief Medical Officer at Eledon Pharmaceuticals. He joined the company from eGenesis, where he previously held the role of Chief Medical Officer. At Eledon Pharmaceuticals, he applies his extensive experience in clinical development and transplantation research to lead the company's medical initiatives.
Vice President of Clinical Development at Viela Bio and Horizon Therapeutics
Eliezer Katz held the position of Vice President of Clinical Development at Viela Bio and continued in this role at Horizon Therapeutics following its acquisition of Viela Bio. During his tenure, he spearheaded the clinical development of inebilizumab in multiple autoimmune indications and played a significant role in the regulatory submission and approval of UPLIZNA®(inebilizumab).
Senior Director Roles in Clinical Development
Katz's wealth of experience includes serving as a Senior Director of Clinical Development at MedImmune Inc. and as Senior Director of Transplantation with the Medicine Development Group at Pfizer. In these roles, he contributed to numerous clinical development projects and initiatives, enhancing the advancement of medical therapies.
Transplant Surgery Career
Eliezer Katz spent two decades practicing as a transplant surgeon. He was the director of the abdominal transplantation division at Integris Baptist Medical Center in Oklahoma City and an associate professor of surgery, as well as the director of the liver transplantation division at the University of Massachusetts Medical Center in Worcester, MA. His work in transplant surgery has been instrumental in advancing the field.
Education and Medical Training
Eliezer Katz earned his M.D. from Hadassah Hebrew University Medical School in Jerusalem. This solid educational foundation paved the way for his extensive career in medicine, particularly in the field of transplantation and clinical development.